{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:48:48Z","timestamp":1755218928739,"version":"3.43.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Pfizer-BioNTech (BNT162b2) is one of the mRNA vaccines currently approved by the WHO and the Food and Drug Administration (FDA) against COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>Here, the authors report a case of an 8-year-old female with Guillain\u2013Barr\u00e9 syndrome following the second dose of Pfizer-BioNTech (BNT162b2) vaccination requiring respiratory support who was managed with intravenous immunoglobulin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>There have been reports of Guillain\u2013Barr\u00e9 syndrome following the Pfizer-BioNTech vaccination. In the authors\u2019 case, as the symptoms of Guillain\u2013Barr\u00e9 syndrome occurred right after the vaccination, there could be an association, and this report can add to the existing literature and raise awareness about the possible adverse effects of the Pfizer-BioNTech vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Although most adverse effects following Pfizer-BioNTech (BNT162b2) vaccination have been reported as non-serious, clinicians must be aware of serious adverse effects that, although rare, can follow the administration of Pfizer-BioNTech vaccination and require prompt recognition and management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002197","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T06:00:16Z","timestamp":1716012016000},"page":"6693-6695","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Guillain\u2013Barre syndrome following Pfizer-BioNTech (BNT162b2) vaccination: a case report"],"prefix":"10.1097","volume":"86","author":[{"given":"Aashutosh","family":"Chaudhary","sequence":"first","affiliation":[{"name":"Kathmandu University School of Medical Sciences, Dhulikhel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrekshya","family":"Khadka","sequence":"additional","affiliation":[{"name":"Nepalese Army Institute of Health Sciences, Sanobharyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliza","family":"Dulal","sequence":"additional","affiliation":[{"name":"Kathmandu University School of Medical Sciences, Dhulikhel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rojeena","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Kathmandu University School of Medical Sciences, Dhulikhel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushant","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Kathmandu University School of Medical Sciences, Dhulikhel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Pandey","sequence":"additional","affiliation":[{"name":"Kathmandu University School of Medical Sciences, Dhulikhel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlesha","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"Everest Hospital Pvt Ltd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzit","family":"Bhusal","sequence":"additional","affiliation":[{"name":"Himal Hospital Pvt Ltd, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smriti","family":"Acharya","sequence":"additional","affiliation":[{"name":"Nepalese Army Institute of Health Sciences, Sanobharyang"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1186\/s12879-021-06863-5","article-title":"COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand","volume":"21","author":"Sirikalyanpaiboon","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2022.03.030","article-title":"Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years","volume":"40","author":"Funk","year":"2022","journal-title":"Vaccine"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1752-1947-7-223","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"7","author":"Gagnier","year":"2013","journal-title":"J Med Case Rep"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"R13-20250806","first-page":"e23526","article-title":"Pfizer-BioNTech COVID-19 vaccine (BNT162b2) side effects: a systematic review","volume":"14","author":"Dighriri","year":"2022","journal-title":"Cureus"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/qjmed\/hcac102","article-title":"Guillain\u2013Barr\u00e9 syndrome after BNT162b2 (Pfizer-BioNTec) vaccination","volume":"115","author":"Takahashi","year":"2022","journal-title":"QJM"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the national influenza immunization program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10072-021-05849-0","article-title":"Guillain-Barr\u00e9 syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea","volume":"43","author":"Kim","year":"2022","journal-title":"Neurol Sci"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10072-021-05733-x","article-title":"Guillain-Barr\u00e9 syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases","volume":"43","author":"Bouattour","year":"2022","journal-title":"Neurol Sci"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.3201\/eid2712.211634","article-title":"Guillain-\u200bBarr\u00e9 syndrome associated with COVID-19 vaccination","volume":"27","author":"Shao","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1111\/ene.14860","article-title":"Prevalence, clinical characteristics and outcomes of Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: a systematic review and meta-analysis","volume":"28","author":"Palaiodimou","year":"2021","journal-title":"Eur J Neurol"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"R23-20250806","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20250806","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. The Guillain-Barr\u00e9 syndrome Study Group.","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jnnp-2020-325815","article-title":"Intravenous immunoglobulin treatment for mild Guillain-Barr\u00e9 syndrome: an international observational study","volume":"92","author":"Verboon","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:08:05Z","timestamp":1754485685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002197","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"2023-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}